Showing results (31-40 of 182) with videos related to
Sort By:
Pageof 19
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 27, 2014
PRRT: Defining the paradigm shift to achieve standardization and individualizationLisa Bodei, Mark Kidd, Richard P Baum, et al.Cancer Biotherapy & Radiopharmaceuticals|February 19, 2004
Radionuclide therapy with iodine-125 and other auger-electron-emitting radionuclides: experimental models and clinical applicationsLisa Bodei, Amin I Kassis, S James Adelstein, et al.Journal of Thoracic Disease|December 5, 2017
The role of peptide receptor radionuclide therapy in advanced/metastatic thoracic neuroendocrine tumorsLisa Bodei, Jarosław B Ćwikla, Mark Kidd, et al.Nature Reviews. Drug Discovery|July 31, 2020
Radiopharmaceutical therapy in cancer: clinical advances and challengesGeorge Sgouros, Lisa Bodei, Michael R McDevitt, et al.Endocrine Connections|October 16, 2014
A PCR blood test outperforms chromogranin A in carcinoid detection and is unaffected by proton pump inhibitorsIrvin M Modlin, Harry Aslanian, Lisa Bodei, et al.Cancer Journal (Sudbury, Mass.)|May 16, 2024
Radiopharmaceuticals for Cancer Diagnosis and Therapy: New Targets, New Therapies-Alpha-Emitters, Novel TargetsNeil K Taunk, Freddy E Escorcia, Jason S Lewis, et al.Neuroendocrinology|September 18, 2014
The status of neuroendocrine tumor imaging: from darkness to light?Lisa Bodei, Anders Sundin, Mark Kidd, et al.Medical Physics|November 3, 2017
Data-driven optimal binning for respiratory motion management in PETAdam L Kesner, Joseph G Meier, Darrell D Burckhardt, et al.PET Clinics|April 8, 2025
Neuroendocrine Tumors: Beta Labeled RadiopeptidesLisa Bodei, Vetri Sudar Jayaprakasam, Bernadette Zhi Ying Wong, et al.Nature Reviews. Clinical Oncology|June 21, 2022
Radiotheranostics in oncology: current challenges and emerging opportunitiesLisa Bodei, Ken Herrmann, Heiko Schöder, et al.Pageof 19